APO Research
Talk to an analyst

APO RESEARCH · REPORT

Myc Proto-Oncogene Protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Myc Proto-Oncogene Protein Industry Growth and Trends Forecast to 2032

19 December 202573 pages

Choose your research edition.

Industry ResearchMyc Proto-Oncogene Protein Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Myc Proto-Oncogene Protein Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Myc Proto-Oncogene Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Myc Proto-Oncogene Protein Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Myc Proto-Oncogene Protein Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Myc Proto-Oncogene Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Myc Proto-Oncogene Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Myc Proto-Oncogene Protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Myc Proto-Oncogene Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Myc Proto-Oncogene Protein include Sorrento Therapeutics, Inc., Phylogica Limited and Dicerna Pharmaceuticals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Myc Proto-Oncogene Protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Myc Proto-Oncogene Protein market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Myc Proto-Oncogene Protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Myc Proto-Oncogene Protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Myc Proto-Oncogene Protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Myc Proto-Oncogene Protein Market by Company

Sorrento Therapeutics, Inc.

Phylogica Limited

Dicerna Pharmaceuticals, Inc.

Myc Proto-Oncogene Protein Segment by Type

DCRM-1711

JY-3094

Others

Myc Proto-Oncogene Protein Segment by Application

Hospital

Clinic

Others

Myc Proto-Oncogene Protein Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Myc Proto-Oncogene Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Myc Proto-Oncogene Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Myc Proto-Oncogene Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Myc Proto-Oncogene Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Myc Proto-Oncogene Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DCRM-1711 Table 2. Major Company of JY-3094 Table 3. Major Company of Others Table 4. Global Myc Proto-Oncogene Protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (K Units) Table 6. Global Myc Proto-Oncogene Protein Sales Market Share in Volume by Type (2021-2026) Table 7. Global Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (US$ Million) Table 8. Global Myc Proto-Oncogene Protein Sales Market Share in Value by Type (2021-2026) Table 9. Global Myc Proto-Oncogene Protein Price by Type (2021-2026) & (US$/Unit) Table 10. Global Myc Proto-Oncogene Protein Sales by Type (2027-2032) & (K Units) Table 11. Global Myc Proto-Oncogene Protein Sales Market Share in Volume by Type (2027-2032) Table 12. Global Myc Proto-Oncogene Protein Sales by Type (2027-2032) & (US$ Million) Table 13. Global Myc Proto-Oncogene Protein Sales Market Share in Value by Type (2027-2032) Table 14. Global Myc Proto-Oncogene Protein Price by Type (2027-2032) & (US$/Unit) Table 15. North America Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (K Units) Table 16. North America Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (K Units) Table 18. Europe Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (K Units) Table 22. Latin America Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Myc Proto-Oncogene Protein Sales by Type (2021-2026) & (US$ Million) Table 25. Myc Proto-Oncogene Protein Industry Trends Table 26. Myc Proto-Oncogene Protein Industry Drivers Table 27. Myc Proto-Oncogene Protein Industry Opportunities and Challenges Table 28. Myc Proto-Oncogene Protein Industry Restraints Table 29. Global Myc Proto-Oncogene Protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Myc Proto-Oncogene Protein Revenue Market Share by Company (2021-2026) Table 31. Global Myc Proto-Oncogene Protein Sales by Company (2021-2026) & (K Units) Table 32. Global Myc Proto-Oncogene Protein Sales Share by Company (2021-2026) Table 33. Global Myc Proto-Oncogene Protein Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Myc Proto-Oncogene Protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Myc Proto-Oncogene Protein Major Company Production Sites and Headquarters Table 36. Global Myc Proto-Oncogene Protein Company, Product Type & Application Table 37. Global Myc Proto-Oncogene Protein Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Myc Proto-Oncogene Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Myc Proto-Oncogene Protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Myc Proto-Oncogene Protein Sales by Region (2021-2026) & (K Units) Table 42. Global Myc Proto-Oncogene Protein Sales Market Share in Volume by Region (2021-2026) Table 43. Global Myc Proto-Oncogene Protein Sales by Region (2021-2026) & (US$ Million) Table 44. Global Myc Proto-Oncogene Protein Sales Market Share in Value by Region (2021-2026) Table 45. Global Myc Proto-Oncogene Protein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Myc Proto-Oncogene Protein Sales by Region (2027-2032) & (K Units) Table 47. Global Myc Proto-Oncogene Protein Sales Market Share in Volume by Region (2027-2032) Table 48. Global Myc Proto-Oncogene Protein Sales by Region (2027-2032) & (US$ Million) Table 49. Global Myc Proto-Oncogene Protein Sales Market Share in Value by Region (2027-2032) Table 50. Global Myc Proto-Oncogene Protein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Myc Proto-Oncogene Protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (K Units) Table 53. Global Myc Proto-Oncogene Protein Sales Market Share in Volume by Application (2021-2026) Table 54. Global Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (US$ Million) Table 55. Global Myc Proto-Oncogene Protein Sales Market Share in Value by Application (2021-2026) Table 56. Global Myc Proto-Oncogene Protein Price by Application (2021-2026) & (US$/Unit) Table 57. Global Myc Proto-Oncogene Protein Sales by Application (2027-2032) & (K Units) Table 58. Global Myc Proto-Oncogene Protein Sales Market Share in Volume by Application (2027-2032) Table 59. Global Myc Proto-Oncogene Protein Sales by Application (2027-2032) & (US$ Million) Table 60. Global Myc Proto-Oncogene Protein Sales Market Share in Value by Application (2027-2032) Table 61. Global Myc Proto-Oncogene Protein Price by Application (2027-2032) & (US$/Unit) Table 62. North America Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (K Units) Table 63. North America Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (K Units) Table 65. Europe Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (K Units) Table 69. Latin America Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Myc Proto-Oncogene Protein Sales by Application (2021-2026) & (US$ Million) Table 72. Sorrento Therapeutics, Inc. Company Information Table 73. Sorrento Therapeutics, Inc. Business Overview Table 74. Sorrento Therapeutics, Inc. Myc Proto-Oncogene Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sorrento Therapeutics, Inc. Myc Proto-Oncogene Protein Product Portfolio Table 76. Sorrento Therapeutics, Inc. Recent Development Table 77. Phylogica Limited Company Information Table 78. Phylogica Limited Business Overview Table 79. Phylogica Limited Myc Proto-Oncogene Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Phylogica Limited Myc Proto-Oncogene Protein Product Portfolio Table 81. Phylogica Limited Recent Development Table 82. Dicerna Pharmaceuticals, Inc. Company Information Table 83. Dicerna Pharmaceuticals, Inc. Business Overview Table 84. Dicerna Pharmaceuticals, Inc. Myc Proto-Oncogene Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Dicerna Pharmaceuticals, Inc. Myc Proto-Oncogene Protein Product Portfolio Table 86. Dicerna Pharmaceuticals, Inc. Recent Development Table 87. North America Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 88. North America Myc Proto-Oncogene Protein Sales by Country (2021-2026) & (K Units) Table 89. North America Myc Proto-Oncogene Protein Sales Market Share by Country (2021-2026) Table 90. North America Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032) & (K Units) Table 91. North America Myc Proto-Oncogene Protein Sales Market Share Forecast by Country (2027-2032) Table 92. North America Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 93. North America Myc Proto-Oncogene Protein Market Size by Country (2021-2026) & (US$ Million) Table 94. North America Myc Proto-Oncogene Protein Market Share by Country (2021-2026) Table 95. North America Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 96. North America Myc Proto-Oncogene Protein Market Share Forecast by Country (2027-2032) Table 97. Europe Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. Europe Myc Proto-Oncogene Protein Sales by Country (2021-2026) & (K Units) Table 99. Europe Myc Proto-Oncogene Protein Sales Market Share by Country (2021-2026) Table 100. Europe Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032) & (K Units) Table 101. Europe Myc Proto-Oncogene Protein Sales Market Share Forecast by Country (2027-2032) Table 102. Europe Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. Europe Myc Proto-Oncogene Protein Market Size by Country (2021-2026) & (US$ Million) Table 104. Europe Myc Proto-Oncogene Protein Market Share by Country (2021-2026) Table 105. Europe Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. Europe Myc Proto-Oncogene Protein Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Myc Proto-Oncogene Protein Sales by Country (2021-2026) & (K Units) Table 109. Asia-Pacific Myc Proto-Oncogene Protein Sales Market Share by Country (2021-2026) Table 110. Asia-Pacific Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032) & (K Units) Table 111. Asia-Pacific Myc Proto-Oncogene Protein Sales Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Myc Proto-Oncogene Protein Market Size by Country (2021-2026) & (US$ Million) Table 114. Asia-Pacific Myc Proto-Oncogene Protein Market Share by Country (2021-2026) Table 115. Asia-Pacific Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Asia-Pacific Myc Proto-Oncogene Protein Market Share Forecast by Country (2027-2032) Table 117. Latin America Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Latin America Myc Proto-Oncogene Protein Sales by Country (2021-2026) & (K Units) Table 119. Latin America Myc Proto-Oncogene Protein Sales Market Share by Country (2021-2026) Table 120. Latin America Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032) & (K Units) Table 121. Latin America Myc Proto-Oncogene Protein Sales Market Share Forecast by Country (2027-2032) Table 122. Latin America Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Latin America Myc Proto-Oncogene Protein Market Size by Country (2021-2026) & (US$ Million) Table 124. Latin America Myc Proto-Oncogene Protein Market Share by Country (2021-2026) Table 125. Latin America Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Latin America Myc Proto-Oncogene Protein Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Myc Proto-Oncogene Protein Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Myc Proto-Oncogene Protein Sales Market Share by Country (2021-2026) Table 130. Middle East and Africa Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032) & (K Units) Table 131. Middle East and Africa Myc Proto-Oncogene Protein Sales Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Myc Proto-Oncogene Protein Market Size by Country (2021-2026) & (US$ Million) Table 134. Middle East and Africa Myc Proto-Oncogene Protein Market Share by Country (2021-2026) Table 135. Middle East and Africa Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Middle East and Africa Myc Proto-Oncogene Protein Market Share Forecast by Country (2027-2032) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Myc Proto-Oncogene Protein Distributors List Table 140. Myc Proto-Oncogene Protein Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Myc Proto-Oncogene Protein Image Figure 2. Global Myc Proto-Oncogene Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Myc Proto-Oncogene Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Myc Proto-Oncogene Protein Sales (2021-2032) & (K Units) Figure 5. DCRM-1711 Image Figure 6. Global DCRM-1711 Sales YoY Growth (2021-2032) & (K Units) Figure 7. JY-3094 Image Figure 8. Global JY-3094 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Myc Proto-Oncogene Protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Myc Proto-Oncogene Protein Market Share by Type 2025 VS 2032 Figure 13. North America Myc Proto-Oncogene Protein Sales Market Share in Volume by Type in 2025 Figure 14. North America Myc Proto-Oncogene Protein Sales Market Share in Value by Type in 2025 Figure 15. Europe Myc Proto-Oncogene Protein Sales Market Share in Volume by Type in 2025 Figure 16. Europe Myc Proto-Oncogene Protein Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Myc Proto-Oncogene Protein Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Myc Proto-Oncogene Protein Sales Market Share in Value by Type in 2025 Figure 19. Latin America Myc Proto-Oncogene Protein Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Myc Proto-Oncogene Protein Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Myc Proto-Oncogene Protein Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Myc Proto-Oncogene Protein Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Myc Proto-Oncogene Protein Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Myc Proto-Oncogene Protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Myc Proto-Oncogene Protein Market Share by Application 2025 VS 2032 Figure 33. North America Myc Proto-Oncogene Protein Sales Market Share in Volume by Application in 2025 Figure 34. North America Myc Proto-Oncogene Protein Sales Market Share in Value by Application in 2025 Figure 35. Europe Myc Proto-Oncogene Protein Sales Market Share in Volume by Application in 2025 Figure 36. Europe Myc Proto-Oncogene Protein Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Myc Proto-Oncogene Protein Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Myc Proto-Oncogene Protein Sales Market Share in Value by Application in 2025 Figure 39. Latin America Myc Proto-Oncogene Protein Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Myc Proto-Oncogene Protein Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Myc Proto-Oncogene Protein Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Myc Proto-Oncogene Protein Sales Market Share in Value by Application in 2025 Figure 43. North America Myc Proto-Oncogene Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Myc Proto-Oncogene Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Myc Proto-Oncogene Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Myc Proto-Oncogene Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Myc Proto-Oncogene Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Myc Proto-Oncogene Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Myc Proto-Oncogene Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Myc Proto-Oncogene Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Myc Proto-Oncogene Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Myc Proto-Oncogene Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Myc Proto-Oncogene Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Myc Proto-Oncogene Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Myc Proto-Oncogene Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Myc Proto-Oncogene Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Myc Proto-Oncogene Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Myc Proto-Oncogene Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Myc Proto-Oncogene Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Myc Proto-Oncogene Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Myc Proto-Oncogene Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Myc Proto-Oncogene Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Myc Proto-Oncogene Protein Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Myc Proto-Oncogene Protein Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • DCRM-1711
  • JY-3094
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sorrento Therapeutics, Inc.
  • Phylogica Limited
  • Dicerna Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Myc Proto-Oncogene Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Myc Proto-Oncogene Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Myc Proto-Oncogene Protein Market by Type
  6. 1.3.1 DCRM-1711
  7. 1.3.2 JY-3094
  8. 1.3.3 Others
  9. 1.4 Global Myc Proto-Oncogene Protein Market Size by Type
  10. 1.4.1 Global Myc Proto-Oncogene Protein Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Myc Proto-Oncogene Protein Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Myc Proto-Oncogene Protein Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Myc Proto-Oncogene Protein Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Myc Proto-Oncogene Protein Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Myc Proto-Oncogene Protein Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Myc Proto-Oncogene Protein Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Myc Proto-Oncogene Protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Myc Proto-Oncogene Protein Industry Trends
  2. 2.2 Myc Proto-Oncogene Protein Industry Drivers
  3. 2.3 Myc Proto-Oncogene Protein Industry Opportunities and Challenges
  4. 2.4 Myc Proto-Oncogene Protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Myc Proto-Oncogene Protein Revenue (2021-2026)
  2. 3.2 Global Top Players by Myc Proto-Oncogene Protein Sales (2021-2026)
  3. 3.3 Global Top Players by Myc Proto-Oncogene Protein Price (2021-2026)
  4. 3.4 Global Myc Proto-Oncogene Protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Myc Proto-Oncogene Protein Major Company Production Sites & Headquarters
  6. 3.6 Global Myc Proto-Oncogene Protein Company, Product Type & Application
  7. 3.7 Global Myc Proto-Oncogene Protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Myc Proto-Oncogene Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Myc Proto-Oncogene Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Myc Proto-Oncogene Protein Tier 1, Tier 2, and Tier 3
4 Myc Proto-Oncogene Protein Regional Status and Outlook
  1. 4.1 Global Myc Proto-Oncogene Protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Myc Proto-Oncogene Protein Historic Market Size by Region
  3. 4.2.1 Global Myc Proto-Oncogene Protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Myc Proto-Oncogene Protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Myc Proto-Oncogene Protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Myc Proto-Oncogene Protein Forecasted Market Size by Region
  7. 4.3.1 Global Myc Proto-Oncogene Protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Myc Proto-Oncogene Protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Myc Proto-Oncogene Protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Myc Proto-Oncogene Protein by Application
  1. 5.1 Myc Proto-Oncogene Protein Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Myc Proto-Oncogene Protein Market Size by Application
  6. 5.2.1 Global Myc Proto-Oncogene Protein Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Myc Proto-Oncogene Protein Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Myc Proto-Oncogene Protein Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Myc Proto-Oncogene Protein Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Myc Proto-Oncogene Protein Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Myc Proto-Oncogene Protein Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Myc Proto-Oncogene Protein Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Myc Proto-Oncogene Protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sorrento Therapeutics, Inc.
  2. 6.1.1 Sorrento Therapeutics, Inc. Company Information
  3. 6.1.2 Sorrento Therapeutics, Inc. Business Overview
  4. 6.1.3 Sorrento Therapeutics, Inc. Myc Proto-Oncogene Protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sorrento Therapeutics, Inc. Myc Proto-Oncogene Protein Product Portfolio
  6. 6.1.5 Sorrento Therapeutics, Inc. Recent Developments
  7. 6.2 Phylogica Limited
  8. 6.2.1 Phylogica Limited Company Information
  9. 6.2.2 Phylogica Limited Business Overview
  10. 6.2.3 Phylogica Limited Myc Proto-Oncogene Protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Phylogica Limited Myc Proto-Oncogene Protein Product Portfolio
  12. 6.2.5 Phylogica Limited Recent Developments
  13. 6.3 Dicerna Pharmaceuticals, Inc.
  14. 6.3.1 Dicerna Pharmaceuticals, Inc. Company Information
  15. 6.3.2 Dicerna Pharmaceuticals, Inc. Business Overview
  16. 6.3.3 Dicerna Pharmaceuticals, Inc. Myc Proto-Oncogene Protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dicerna Pharmaceuticals, Inc. Myc Proto-Oncogene Protein Product Portfolio
  18. 6.3.5 Dicerna Pharmaceuticals, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Myc Proto-Oncogene Protein Sales by Country
  2. 7.1.1 North America Myc Proto-Oncogene Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Myc Proto-Oncogene Protein Sales by Country (2021-2026)
  4. 7.1.3 North America Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Myc Proto-Oncogene Protein Market Size by Country
  6. 7.2.1 North America Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Myc Proto-Oncogene Protein Market Size by Country (2021-2026)
  8. 7.2.3 North America Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Myc Proto-Oncogene Protein Sales by Country
  2. 8.1.1 Europe Myc Proto-Oncogene Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Myc Proto-Oncogene Protein Sales by Country (2021-2026)
  4. 8.1.3 Europe Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Myc Proto-Oncogene Protein Market Size by Country
  6. 8.2.1 Europe Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Myc Proto-Oncogene Protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Myc Proto-Oncogene Protein Sales by Country
  2. 9.1.1 Asia-Pacific Myc Proto-Oncogene Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Myc Proto-Oncogene Protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Myc Proto-Oncogene Protein Market Size by Country
  6. 9.2.1 Asia-Pacific Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Myc Proto-Oncogene Protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Myc Proto-Oncogene Protein Sales by Country
  2. 10.1.1 South America Myc Proto-Oncogene Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Myc Proto-Oncogene Protein Sales by Country (2021-2026)
  4. 10.1.3 South America Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Myc Proto-Oncogene Protein Market Size by Country
  6. 10.2.1 South America Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Myc Proto-Oncogene Protein Market Size by Country (2021-2026)
  8. 10.2.3 South America Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Myc Proto-Oncogene Protein Sales by Country
  2. 11.1.1 Middle East and Africa Myc Proto-Oncogene Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Myc Proto-Oncogene Protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Myc Proto-Oncogene Protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Myc Proto-Oncogene Protein Market Size by Country
  6. 11.2.1 Middle East and Africa Myc Proto-Oncogene Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Myc Proto-Oncogene Protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Myc Proto-Oncogene Protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Myc Proto-Oncogene Protein Value Chain Analysis
  2. 12.1.1 Myc Proto-Oncogene Protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Myc Proto-Oncogene Protein Production Mode & Process
  7. 12.2 Myc Proto-Oncogene Protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Myc Proto-Oncogene Protein Distributors
  10. 12.2.3 Myc Proto-Oncogene Protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst